Device therapies in Heart failure continuum of care: time to treat!

Event : HFA Discoveries 2020

• Session : Device therapies in Heart failure continuum of care : time to treat!
• Speaker : J Bax (Leiden,NL), M Senni (Bergamo,IT), A Chow (London,GB), R Von Bardeleben (Mainz,DE), JJ Brugts (Rotterdam,NL), A Coats (Warwickshire,GB)

• Sponsored by Abbott

Pulmonary artery pressure monitoring in LVAD patients: The Cardiologist’s Perspective; Take-Home message.

Event : HFA Discoveries 2020

• Session : Device therapies in Heart failure continuum of care : time to treat!
• Speaker : JJ Brugts (Rotterdam,NL), J Bax (Leiden,NL), A Coats (Warwickshire,GB)

• Sponsored by Abbott

Integrating diagnostic data from implanted devices for improved patient management.

Event : EHRA 2019

• Session : Novel approaches in heart failure management
• Speaker : JJ Brugts (Rotterdam,NL)

• Sponsored by Abbott

Optimizing LVAD therapy in advanced heart failure by means of PAP monitoring.

Event : Heart Failure 2019

• Session : Advances in heart failure management: what if you can do more for more patients?
• Speaker : JJ Brugts (Rotterdam,NL)

• Sponsored by Abbott

Real-world heart failure treatment in 10.330 patients with chronic heart failure in the netherlands

Event : Heart Failure 2017

• Session : Clinical Forum - Sat. 29 April 08:30 - Tues. 02 May at 12:30
• Speaker : JJ Brugts (Rotterdam,NL)

The treatment benefit of the ACE-inhibitor perindopril on top of beta-blocker therapy in patients with vascular disease

Event : ESC Congress 2016

• Session : Cardiovascular prevention outcomes I
• Speaker : JJ Brugts (Rotterdam,NL)

Clinical predictors of ACE-inhibitor induced dry cough in 27492 patients with cardiovascular disease using individual data of randomized clinical trials

Event : ESC Congress 2013

• Session : Cardiovascular risk
• Speaker : JJ Brugts (Rotterdam,NL)